PYREXIA is the #2 most commonly reported adverse reaction for FLUDARABINE PHOSPHATE, manufactured by Fresenius Kabi USA, LLC. There are 2,873 FDA adverse event reports linking FLUDARABINE PHOSPHATE to PYREXIA. This represents approximately 3.6% of all 79,367 adverse event reports for this drug.
Patients taking FLUDARABINE PHOSPHATE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA2,873 of 79,367 reports
PYREXIA is moderately reported among FLUDARABINE PHOSPHATE users, representing a notable but not dominant share of adverse events.
Other Side Effects of FLUDARABINE PHOSPHATE
In addition to pyrexia, the following adverse reactions have been reported for FLUDARABINE PHOSPHATE:
PYREXIA has been reported as an adverse event in 2,873 FDA reports for FLUDARABINE PHOSPHATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with FLUDARABINE PHOSPHATE?
PYREXIA accounts for approximately 3.6% of all adverse event reports for FLUDARABINE PHOSPHATE, making it one of the most commonly reported side effect.
What should I do if I experience PYREXIA while taking FLUDARABINE PHOSPHATE?
If you experience pyrexia while taking FLUDARABINE PHOSPHATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.